STOCK GOODIES PLAYS OF THE WEEK

[TradingForLiving]

Why TLPEQ 0.0003 Will Be a 5000-10000% Gainer ( MUST READ )

TLPEQ. One of the better BK plays may be coming online. Marius Silvasan’s wife,
Jeanne Chan, is the registered agent for a LLC in Florida formed last month where
Silvasan is listed as a Manager.

sunbiz.org/scripts/cordet.exe?action=DETFIL&inq_doc_number=L11000019333&inq_came_from=OFFFWD&cor_web_names_seq_number=0003&names_name_ind=P&ret_names_cor_number=&ret_cor_web_names_seq_number=&ret_names_name_ind=&ret_names_comp_name=&ret_names_filing_type=&ret_cor_web_princ_seq=&ret_princ_comp_name=SILVASANMARIUS&ret_princ_type=

Marius Silvasan has retained the shell of teleplus world after the BK with shareholders intact.

The LLC is listed as BRIDGEWATER 605 LLC.
The reference to 605 is the building name and condo number of Damian Chan and
Christian Chan.

1881 79TH STREET CSWY #605
NORTH BAY VILLAGE FL 33141 US

Marius Slivasan has recently taken a pinksheet company (CSEV) to the Nasdaq as
One Bio Holdings. (ONBI.) certnas filing was just a week or two ago.

Marius Silvasan was roughly a 10% holder of common shares of TLPEQ with no preferred
shares outstanding at last count.

Marius Silvasan is apparently calling the shots at Abacus World Corp.

http://www.abacusworldcorp.com/index.php?option=com_content&view=article&id=69&Itemid=67&lang=us

Quote:Abacus identifies best in class midsize private companies and works with these
companies to transform them into fast growing public entities. Abacus is experienced
in bringing companies public in the United States, Canada, Germany, England and
Hong Kong. Abacus provides the following services to its portfolio companies:
• Identifies appropriate public exchange most conducive in providing the highest
valuation;
• Designs appropriate corporate and tax structure for company and shareholders prior
to public market entry;
• Creates initial prospectus, private placement, reverse merger documents and
government fillings;
• Files all appropriate regulatory requirements to bring company public; and
• Creates market awareness by announcing the company’s entry in the public market.

It is important for a company to select the appropriate exchange as the wrong decision
can result in (a) unnecessary costs; (b) limited access to capital; (c) access to
capital not catered to the company’s needs; and/or (d) jeopardized company growth.
Abacus works with its portfolio companies to ensure the right decisions are made
prior to entry in the public market.
Abacus’ turn-key solution is a guaranteed success. Abacus involvement stretches
from prior to post public entry with extensive benefits:
• Abacus provides guidance and coaching allowing a smooth transition from a private
entity to a world-class public entity with proper corporate governance;
• Abacus enables the company to build long term sustainable market valuation;
• Abacus brings capital; and
• Abacus creates a solid corporate image.

TLPEQ CEO is Marius Silvasan

Marius Silvasan is also Chairman, CEO and Director of Abacus World Corp.http://www.abacusworldcorp.com/index.php?option=com_content&view=article&id=48&Itemid=74&lang=us

Abacus World Corp. specializes in Reverse Merger Services
http://www.abacusworldcorp.com/index.php?option=com_content&view=article&id=69&Itemid=67&lang=us



There is a difference between chapter 7 liquidation, and a chapter 11 settlement.
TLPEQ had the BK dismissed and is listed as a shell corporation on otcmarkets.com.
A lot of people are trying to compare dead companies with shell corps. How many
shell plays are actually listed as such on otcmarkets? Not many.

The last company that Marius took public is currently listed @ over $4.00 per share.
Even though he is listed as CEO, he was just hired to take a private company public.
The private pharmaceutical company that wanted to go public was Sanming Hujian
Bioengineering Co., LTD whose CEO was Min Zhao, which hired Abacus to take them public.

If you look at the 8-K filed for One Bio (ONBI) on 6-10-2009 Silvasan seems to
enlist the help of Belmont Partners and Joseph Meuse to acquire Contracted Services
and complete the Merger of Sanming to create the new publicly traded entity.

With TLPEQ, he has got the shell, the team and the connections to successfully
complete a merger IMO.

There is certainly risk involved, but if Abacus finds a turtle to stuff into
this shell, the rewards could be big. IMO and FWIW.

http://www.abacusworldcorp.com/index.php?view=article&catid=47%3Apress&id=93%3A2008-07-08-15-21-27&option=com_content&Itemid=83&lang=us

Quote:
MIAMI, FL – June 24th, 2008 – Abacus World, Corp. (www.abacusworldcorp.com)
(“Abacus” or the “Company”), a business advisory firm catered to help small
and midsized companies reach their full potential, announced that it has
entered into an agreement with Sanming Hujian Bioengineering Co., LTD (“Sanming”)
to provide certain services.

As part of the agreement, Abacus is to provide services which include, but
are not limited to, bringing Sanming public in the United States, providing general
consulting and advisory services, and introducing Sanming to institutional
investors and high net worth individuals to raise capital for growth.

“We are very pleased with the Sanming engagement. We have focused resources
and energy in the last few months in developing our Asian presence. We are
focused in growing our portfolio of good profitable businesses in select markets.
We strongly believe the Asian market, with China in particular, is well positioned
to deliver sustainable growth. Our strategy is to place investors into winning
companies and assist said companies to reach their strategic growth and profit
objectives,” stated Michael Karpheden, CEO and President of Abacus.

“We are confident that we have selected the right partner in Abacus to bring our
firm public in the United States and assist us reaching our operational objectives
while maximizing returns to our investors. We look forward to a long term
relationship with Abacus. The market for our products which includes Solanesol,
Nicotine Sulphate and CoQ10 is in high growth and are determined to take a large
part of that market,” stated Mr. Min Zhao Sanming’s CEO and President.